SUBSCRIBE
SUBSCRIBE
News   Business

Biogen Idec, Inc. (Massachusetts) Increases Revenue 18% to $1.4 Billion in the Second Quarter

July 24, 2012 | 
1 min read
WESTON, Mass.--(BUSINESS WIRE) Biogen Idec Inc. (NASDAQ: BIIB), a global biotechnology leader in the discovery, development, manufacturing and commercialization of innovative therapies, today announced its second quarter 2012 results.
Earnings
Biogen
MORE ON THIS TOPIC
Hands offering money with a circular chart at the center, symbolizing shareholder equity, crowdfunding, business partnerships, and investments
IPO
Radiopharma-Focused Aktis Squeezes in IPO to End Biotech Drought
December 22, 2025
 · 
1 min read
 · 
Annalee Armstrong
Upward arrow on the background of the flag of China. Paper plane. Economic recovery. Copy space. Business. Background.
China
AstraZeneca Finds Another Jewel in China With up to $2B For KRAS Inhibitor
December 22, 2025
 · 
1 min read
 · 
Annalee Armstrong
Digital overload and its impact on the human brain, showcasing fragmented thoughts, information overload. Abstract design art collage. Social media digital addiction, mental health, stress, anxiety
Business
BioSpace Editors’ Top 5 Biggest News Stories of the Year
December 22, 2025
 · 
10 min read
 · 
Annalee Armstrong
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Voyager Loses 30 Employees After Novartis Prunes Deal
December 19, 2025
 · 
98 min read
 · 
BioSpace Editorial Staff